Report cover image

United Kingdom Cardiac Disease Market Outlook to 2033 - Cardiac Marker Tests

Publisher GlobalData
Published Jun 23, 2025
Length 31 Pages
SKU # GBDT20178241

Description

United Kingdom Cardiac Disease Market Outlook to 2033 - Cardiac Marker Tests

Summary

GlobalData’s “United Kingdom Cardiac Disease Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United Kingdom Cardiac Disease market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cardiac Marker Tests

The United Kingdom Cardiac Disease Market report provides key information and data on -
  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2024 company share data for Cardiac Disease Market.
  • Global corporate-level profiles of key companies operating within the United Kingdom Cardiac Disease Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope

United Kingdom Cardiac Disease is segmented as follows -
  • Cardiac Marker Tests
Reasons to Buy

The United Kingdom Cardiac Disease Market report helps you to develop -
  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table of Contents

31 Pages
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Cardiac Disease Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Cardiac Disease Market, United Kingdom
3.1 Cardiac Disease Market, United Kingdom, Revenue ($m), 2018-2033
3.1.1 Cardiac Marker Tests Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.2 Cardiac Disease Market, United Kingdom, Volume (Units), 2018-2033
3.2.1 Cardiac Marker Tests Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.3 Cardiac Disease Market, United Kingdom, Average Price ($), 2018-2033
3.4 Cardiac Disease Market, United Kingdom, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in United Kingdom, Cardiac Disease Market
4.1 F. Hoffmann-La Roche Ltd
4.1.1 Company Overview
4.2 Abbott Laboratories
4.2.1 Company Overview
4.3 Siemens Healthineers AG
4.3.1 Company Overview
4.4 Danaher Corp
4.4.1 Company Overview
4.5 Quidelortho Corp
4.5.1 Company Overview
4.6 bioMerieux SA
4.6.1 Company Overview
5 Cardiac Disease Market Pipeline Products
6 Financial Deals Landscape
6.1 Equity Offerings
6.1.1 EDX Medical Group Raises USD0.38 Million in Private Placement of Shares
7 Recent Developments
7.1 Corporate Communications
7.1.1 Sep 30, 2024: EDX Medical Group: Annual General Meeting Results
7.2 Financial Announcements
7.2.1 Sep 04, 2024: EDX Medical Group Releases Annual Report and Financial Statements for the Period Ending March 31, 2024
7.3 Other Significant Developments
7.3.1 Sep 20, 2024: Funding Supports Neuranics’ Groundbreaking AI Technology for Remote Heart Health Monitoring
7.4 Strategy And Business Planning
7.4.1 Sep 20, 2024: Funding Supports Neuranics’ Groundbreaking AI Technology for Remote Heart Health Monitoring
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer
List of Tables
Table 1: Cardiac Disease Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 2: Cardiac Marker Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 3: Cardiac Disease Market, United Kingdom, Volume (Units), 2018-2033
Table 4: Cardiac Marker Tests Market, United Kingdom, Volume (Units), 2018-2033
Table 5: Cardiac Disease Market, United Kingdom, Average Price ($), 2018-2033
Table 6: Cardiac Disease Market, United Kingdom, Company Share by Revenue ($m), 2024
Table 7: Cardiac Disease Market Pipeline Products
Table 8: EDX Medical Group Raises USD0.38 Million in Private Placement of Shares
Table 9: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Cardiac Disease Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 2: Cardiac Marker Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 3: Cardiac Disease Market, United Kingdom, Volume (Units), 2018-2033
Figure 4: Cardiac Marker Tests Market, United Kingdom, Volume (Units), 2018-2033
Figure 5: Cardiac Disease Market, United Kingdom, Company Share (%), 2024

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us